Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bioventus Inc.

    NASDAQ: BVS · Real-Time Price · USD
    6.47
    -0.09 (-1.37%)
    At close: May 30, 2025, 3:59 PM
    6.48
    0.08%
    After-hours: May 30, 2025, 04:20 PM EDT
    -1.37%
    Bid 6.08
    Market Cap 429.67M
    Revenue (ttm) 567.7M
    Net Income (ttm) -31.61M
    EPS (ttm) -0.48
    PE Ratio (ttm) -13.49
    Forward PE 7.38
    Analyst Buy
    Ask 6.9
    Volume 206,081
    Avg. Volume (20D) 426,272
    Open 6.54
    Previous Close 6.56
    Day's Range 6.41 - 6.67
    52-Week Range 5.28 - 14.38
    Beta 0.95

    About BVS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BVS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BVS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 weeks ago
    -11.81%
    Bioventus shares are trading lower following Q1 re... Unlock content with Pro Subscription
    2 months ago
    +23.29%
    Bioventus shares are trading higher after the company reported better-than-expected Q4 financial results.
    news image

    3 weeks ago · seekingalpha.com

    Bioventus Inc. (BVS) Q1 2025 Earnings Call Transcript

    Bioventus Inc. (NASDAQ:BVS ) Q1 2025 Results Conference Call May 6, 2025 8:30 AM ET Company Participants Dave Crawford - Investor Relations Rob Claypoole - President & Chief Executive Officer Mark Sin...

    news image

    3 weeks ago · zacks.com

    Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates

    Bioventus (BVS) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.07 per share a year ago.

    news image

    1 month ago · zacks.com

    4 Healthcare Stocks to Buy as the Sector Faces Government Heat

    Buy healthcare stocks like WGS, THC, RIGL and ENSG for steady returns as the focus shifts to the Trump administration's healthcare policies.

    news image

    2 months ago · zacks.com

    Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now

    Bioventus (BVS) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a tr...

    news image

    2 months ago · zacks.com

    Bioventus (BVS) Upgraded to Buy: Here's What You Should Know

    Bioventus (BVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

    news image

    2 months ago · seekingalpha.com

    Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript

    Bioventus Inc. (NASDAQ:BVS ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Dave Crawford - Investor Relations Rob Claypoole - President & Chief Executive Officer Mark...

    news image

    2 months ago · benzinga.com

    Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million

    On Tuesday, Bioventus Inc. BVS reported fourth-quarter adjusted EPS of 15 cents, up from 7 cents, beating the consensus of 8 cents.

    news image

    2 months ago · zacks.com

    Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates

    Bioventus (BVS) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.07 per share a year ago.

    Add to Watchlist